Literature DB >> 24439070

A myriad of methods: calculated sample size for two proportions was dependent on the choice of sample size formula and software.

Melanie L Bell1, Armando Teixeira-Pinto2, Joanne E McKenzie3, Jake Olivier4.   

Abstract

OBJECTIVES: Several methods exist to calculate sample size for the difference of proportions (risk difference). Researchers are often unaware that there are different formulae, different underlying assumptions, and what the impact of choice of formula is on the calculated sample size. The aim of this study was to discuss and compare different sample size formulae for the risk difference. STUDY DESIGN AND
SETTING: Four sample size formulae were used to calculate sample size for nine scenarios. Software documentation for SAS, Stata, G*Power, PASS, StatXact, and several R libraries were searched for default assumptions. Each package was used to calculate sample size for two scenarios.
RESULTS: We demonstrate that for a set of parameters, sample size can vary as much as 60% depending on the formula used. Varying software and assumptions yielded discrepancies of 78% and 7% between the smallest and largest calculated sizes, respectively. Discrepancies were most pronounced when powering for large risk differences. The default assumptions varied considerably between software packages, and defaults were not clearly documented.
CONCLUSION: Researchers should be aware of the assumptions in power calculations made by different statistical software packages. Assumptions should be explicitly stated in grant proposals and manuscripts and should match proposed analyses. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binary; Continuity correction; Difference in proportions; Power; Risk difference; Sample size; Statistical software

Mesh:

Year:  2014        PMID: 24439070     DOI: 10.1016/j.jclinepi.2013.10.008

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  New guidance to improve sample size calculations for trials: eliciting the target difference.

Authors:  Melanie L Bell
Journal:  Trials       Date:  2018-11-05       Impact factor: 2.279

2.  Early PARacetamol (EPAR) trial: a study protocol for a randomised controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants.

Authors:  Tim Schindler; John Smyth; Srinivas Bolisetty; Joanna Michalowski; Kei Lui
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.